Surgery Total Current Assets from 2010 to 2024

SGRY Stock  USD 23.01  0.34  1.46%   
Surgery Partners Total Current Assets yearly trend continues to be fairly stable with very little volatility. Total Current Assets will likely drop to about 626.5 M in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2014-03-31
Previous Quarter
B
Current Value
B
Quarterly Volatility
270 M
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Surgery Partners over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Surgery Partners' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Surgery Total Current Assets Regression Statistics

Arithmetic Mean475,914,653
Geometric Mean340,421,828
Coefficient Of Variation67.59
Mean Deviation274,640,210
Median525,500,000
Standard Deviation321,650,210
Sample Variance103458.9T
Range863.6M
R-Value0.92
Mean Square Error16541.9T
R-Squared0.85
Slope66,369,602
Total Sum of Squares1448424T

Surgery Total Current Assets History

2024626.5 M
2023895 M
2022921 M
2021946.1 M
2020801.5 M
2019525.5 M
2018588.3 M

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Total Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets895 M626.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.